Literature DB >> 21263101

Early evaluation of tumoral response to antiangiogenic therapy by arterial spin labeling perfusion magnetic resonance imaging and susceptibility weighted imaging in a patient with recurrent glioblastoma receiving bevacizumab.

Slim Fellah1, Nadine Girard, Olivier Chinot, Patrick J Cozzone, Virginie Callot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21263101     DOI： 10.1200/JCO.2010.32.6082

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

Review 1.  Clinical oncologic applications of PET/MRI: a new horizon.

Authors:  Sasan Partovi; Andres Kohan; Christian Rubbert; Jose Luis Vercher-Conejero; Chiara Gaeta; Roger Yuh; Lisa Zipp; Karin A Herrmann; Mark R Robbin; Zhenghong Lee; Raymond F Muzic; Peter Faulhaber; Pablo R Ros
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

2.  Antiangiogenic Effect of Bevacizumab: Application of Arterial Spin-Labeling Perfusion MR Imaging in a Rat Glioblastoma Model.

Authors:  T J Yun; H R Cho; S H Choi; H Kim; J-K Won; S-W Park; J-H Kim; C-H Sohn; M H Han
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-12       Impact factor: 3.825

3.  Pseudo-continuous arterial spin labeling reflects vascular density and differentiates angiomatous meningiomas from non-angiomatous meningiomas.

Authors:  Shinichiro Koizumi; Naoto Sakai; Hiroshi Kawaji; Yasuo Takehara; Shuhei Yamashita; Harumi Sakahara; Satoshi Baba; Hisaya Hiramatsu; Tetsuro Sameshima; Hiroki Namba
Journal:  J Neurooncol       Date:  2014-12-06       Impact factor: 4.130

4.  Pediatric phase II trials of poly-ICLC in the management of newly diagnosed and recurrent brain tumors.

Authors:  Lisa L R Hartman; John R Crawford; Milan T Makale; Mehrzad Milburn; Shweta Joshi; Andres M Salazar; Beth Hasenauer; Scott R VandenBerg; Tobey J MacDonald; Donald L Durden
Journal:  J Pediatr Hematol Oncol       Date:  2014-08       Impact factor: 1.289

5.  Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation.

Authors:  Antonello Vidiri; Andrea Pace; Alessandra Fabi; Marta Maschio; Gaetano Marco Latagliata; Vincenzo Anelli; Francesca Piludu; Carmine Maria Carapella; Giuseppe Giovinazzo; Simona Marzi
Journal:  J Exp Clin Cancer Res       Date:  2012-04-11

6.  Early-stage imaging of nanocarrier-enhanced chemotherapy response in living subjects by scalable photoacoustic microscopy.

Authors:  Liming Nie; Peng Huang; Weitao Li; Xuefeng Yan; Albert Jin; Zhe Wang; Yuxia Tang; Shouju Wang; Xiaofen Zhang; Gang Niu; Xiaoyuan Chen
Journal:  ACS Nano       Date:  2014-11-21       Impact factor: 15.881

Review 7.  A neuroradiologist's guide to arterial spin labeling MRI in clinical practice.

Authors:  M Grade; J A Hernandez Tamames; F B Pizzini; E Achten; X Golay; M Smits
Journal:  Neuroradiology       Date:  2015-09-09       Impact factor: 2.804

8.  Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma.

Authors:  Anne Clavreul; Emilie Roger; Milad Pourbaghi-Masouleh; Laurent Lemaire; Clément Tétaud; Philippe Menei
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.